Lingdancao Granules in the Treatment of Seasonal Influenza

Summary

Name of study: Randomized, Double-Blinded, Oseltamivir-and-Placebo-Controlled Clinical Study about Lingdancao Granules in the Treatment of Seasonal Influenza Objective: Preliminary evaluation on the efficacy and safety of Lingdancao granules in the treatment of seasonal influenza Design: Multicenter, randomized, double-blind, double parallel analogy, positive drug and placebo controlled trial Case number: This test is expected to be included in 318 cases of 14-65 (≥14 or ≤65) ages of subjects. Qualified participants are randomly divided into experimental drug group (Lingdancao granules group), positive control group (oseltamivir phosphate group) and placebo group, 106 cases in each.

Timeline

Start

2016-04

Primary completion

2017-11

Completion

2017-12

Publications

• He J, Li Z, Huang W, Guan W, Ma H, Yang ZF, Wang X. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial. BMJ Open. 2019 Apr 2;9(4):e024800. doi: 10.1136/bmjopen-2018-024800.

Drugs

Indications